Benton Andrew 4
4 · Ensysce Biosciences, Inc. · Filed Jun 27, 2022
Insider Transaction Report
Form 4
Benton Andrew
Director
Transactions
- Award
Stock Option
2022-06-23+15,000→ 100,850 totalExercise: $0.42Exp: 2032-06-23→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]On June 23, 2022, Mr. Benton was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.